147 related articles for article (PubMed ID: 17552954)
1. A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial.
Black PC; Basen-Engquist K; Wang X; Swartz RJ; Eddings T; Matin SF; Swanson D; Wood CG; Pisters LL; Babaian RJ; Troncoso P; Pettaway CA
BJU Int; 2007 Jul; 100(1):63-9. PubMed ID: 17552954
[TBL] [Abstract][Full Text] [Related]
2. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
[TBL] [Abstract][Full Text] [Related]
3. Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.
Yoon FH; Gardner SL; Danjoux C; Morton G; Cheung P; Choo R
J Urol; 2008 Oct; 180(4):1438-43; discussion 1443-4. PubMed ID: 18710743
[TBL] [Abstract][Full Text] [Related]
4. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
[TBL] [Abstract][Full Text] [Related]
5. How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?
Choo R; Chander S; Danjoux C; Morton G; Pearce A; Deboer G; Szumacher E; Loblaw A; Cheung P; Woo T
Can J Urol; 2005 Feb; 12(1):2547-52. PubMed ID: 15777493
[TBL] [Abstract][Full Text] [Related]
6. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
[TBL] [Abstract][Full Text] [Related]
7. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
[TBL] [Abstract][Full Text] [Related]
8. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
Pathak AS; Pacificar JS; Shapiro CE; Williams SG
J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
Choo R; Pearce A; Danjoux C; Morton G; Deboer G; Szumacher E; Loblaw A; Cheung P
Eur Urol; 2007 Dec; 52(6):1645-50. PubMed ID: 17140722
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of sexual function and sexual bother following autologous sural nerve grafting during radical prostatectomy.
Kuwata Y; Muneuchi G; Igawa HH; Tsukuda F; Inui M; Kakehi Y
Int J Urol; 2007 Jun; 14(6):510-4. PubMed ID: 17593095
[TBL] [Abstract][Full Text] [Related]
11. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
[TBL] [Abstract][Full Text] [Related]
12. The change in the dihydrotestosterone level in the prostate before and after androgen deprivation therapy in connection with prostate cancer aggressiveness using the Gleason score.
Nishiyama T; Ikarashi T; Hashimoto Y; Wako K; Takahashi K
J Urol; 2007 Oct; 178(4 Pt 1):1282-8; discussion 1288-9. PubMed ID: 17698092
[TBL] [Abstract][Full Text] [Related]
13. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
[TBL] [Abstract][Full Text] [Related]
14. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.
Spry NA; Kristjanson L; Hooton B; Hayden L; Neerhut G; Gurney H; Corica T; Korbel E; Weinstein S; McCaul K
Eur J Cancer; 2006 May; 42(8):1083-92. PubMed ID: 16632343
[TBL] [Abstract][Full Text] [Related]
16. Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study.
Malone S; Perry G; Segal R; Dahrouge S; Crook J
BJU Int; 2005 Sep; 96(4):514-20. PubMed ID: 16104902
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes.
Robinson JW; Donnelly BJ; Siever JE; Saliken JC; Ernst SD; Rewcastle JC; Trpkov K; Lau H; Scott C; Thomas B
Cancer; 2009 Oct; 115(20):4695-704. PubMed ID: 19691092
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for prostate cancer: effects on hand function.
Soyupek F; Soyupek S; Perk H; Ozorak A
Urol Oncol; 2008; 26(2):141-6. PubMed ID: 18312932
[TBL] [Abstract][Full Text] [Related]
19. Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery.
Chander S; Choo R; Danjoux C; Morton G; Pearse A; Deboer G; Szumacher E; Loblaw A; Cheung P; Woo T
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):719-24. PubMed ID: 15936551
[TBL] [Abstract][Full Text] [Related]
20. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
